​

iRhythm (IRTC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

IRTC Stock Forecast

iRhythm (IRTC) stock forecast, based on 19 Wall Street analysts, predicts a 12-month average price target of $210.91, with a high of $244.00 and a low of $184.00. This represents a 83.93% increase from the last price of $114.67.

$50 $90 $130 $170 $210 $250 High: $244 Avg: $210.91 Low: $184 Last Closed Price: $114.67

IRTC Stock Rating

iRhythm stock's rating consensus is Buy, based on 19 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 16 Buy (84.21%), 3 Hold (15.79%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 19 0 3 16 Strong Sell Sell Hold Buy Strong Buy

IRTC Price Target Upside V Benchmarks

TypeNameUpside
StockiRhythm83.93%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks31.16%

Price Target Trends

1M3M12M
# Anlaysts3721
Avg Price Target$194.67$206.43$205.00
Last Closing Price$114.67$114.67$114.67
Upside/Downside69.77%80.02%78.77%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 263121--16
Feb, 263121--16
Jan, 263112--16
Dec, 253112--16
Nov, 253112--16
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 23, 2026Goldman Sachs$184.00$150.9621.89%60.46%
Feb 20, 2026Richard NewitterTruist Financial$200.00$147.7735.35%74.41%
Feb 20, 2026Robert W. Baird$200.00$158.8825.88%74.41%
Jan 13, 2026Wells Fargo$225.00$168.9933.14%96.22%
Jan 09, 2026Goldman Sachs$211.00$189.2511.49%84.01%
Jan 05, 2026Vijay KumarEvercore ISI$210.00$175.2219.85%83.13%
Dec 18, 2025Truist Financial$215.00$172.0724.95%87.49%
Dec 02, 2025Morgan Stanley$205.00$182.7412.18%78.77%
Oct 31, 2025David RomanGoldman Sachs$202.00$192.624.87%76.16%
Oct 31, 2025Oppenheimer$225.00$205.009.76%96.22%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 20, 2026William BlairBuyBuyhold
Jan 13, 2026Wells FargoOverweightOverweighthold
Jan 12, 2026Morgan StanleyOverweightOverweighthold
Jan 09, 2026Goldman SachsNeutralNeutralhold
Jan 05, 2026Evercore ISIOutperformupgrade
Dec 02, 2025Morgan StanleyOverweightOverweighthold
Oct 31, 2025Goldman SachsNeutralNeutralhold
Oct 31, 2025OppenheimerOutperformOutperformhold
Oct 31, 2025NeedhamBuyBuyhold
Oct 13, 2025BTIGBuyBuyhold

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 $2 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.46$-3.88$-4.04$-3.63$-1.39---
Avg Forecast$-3.52$-3.46$-3.10$-3.63$-1.83$-0.79$0.73$1.50
High Forecast$-3.49$-3.43$-2.81$-3.41$-1.29$-0.32$0.73$1.51
Low Forecast$-3.55$-3.50$-3.29$-3.83$-2.23$-1.04$0.72$1.48
Surprise %-1.70%12.14%30.32%--24.04%---

Revenue Forecast

$300M $470M $640M $810M $980M $1B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$322.82M$410.92M$492.68M$591.84M$747.14M---
Avg Forecast$319.68M$408.46M$490.37M$584.97M$679.59M$796.87M$959.05M$1.12B
High Forecast$321.25M$412.02M$493.74M$589.84M$682.68M$797.12M$963.15M$1.13B
Low Forecast$317.22M$405.59M$489.34M$582.95M$675.49M$796.63M$951.39M$1.11B
Surprise %0.98%0.60%0.47%1.17%9.94%---

Net Income Forecast

$-200M $-150M $-100M $-50M $0 $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-101.36M$-116.16M$-123.41M$-113.29M$-44.55M---
Avg Forecast$-112.19M$-161.43M$-123.41M$-110.56M$-56.63M$-26.69M$22.23M$45.79M
High Forecast$-89.75M$-129.15M$-98.72M$-104.12M$-39.26M$-9.79M$22.41M$46.05M
Low Forecast$-134.62M$-193.72M$-148.09M$-117.01M$-68.06M$-31.89M$22.05M$45.32M
Surprise %-9.65%-28.05%-2.47%-21.33%---

IRTC Forecast FAQ

Is iRhythm stock a buy?

iRhythm stock has a consensus rating of Buy, based on 19 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 16 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that iRhythm is a favorable investment for most analysts.

What is iRhythm's price target?

iRhythm's price target, set by 19 Wall Street analysts, averages $210.91 over the next 12 months. The price target range spans from $184 at the low end to $244 at the high end, suggesting a potential 83.93% change from the previous closing price of $114.67.

How does iRhythm stock forecast compare to its benchmarks?

iRhythm's stock forecast shows a 83.93% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (31.16%).

What is the breakdown of analyst ratings for iRhythm over the past three months?

  • March 2026: 18.75% Strong Buy, 75.00% Buy, 6.25% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 18.75% Strong Buy, 75.00% Buy, 6.25% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 18.75% Strong Buy, 68.75% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.

What is iRhythm’s EPS forecast?

iRhythm's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.79, marking a -43.17% decrease from the reported $-1.39 in 2025. Estimates for the following years are $0.73 in 2027, and $1.5 in 2028.

What is iRhythm’s revenue forecast?

iRhythm's average annual revenue forecast for its fiscal year ending in December 2026 is $796.87M, reflecting a 6.66% increase from the reported $747.14M in 2025. The forecast for 2027 is $959.05M, and $1.12B for 2028.

What is iRhythm’s net income forecast?

iRhythm's net income forecast for the fiscal year ending in December 2026 stands at $-26.694M, representing a -40.08% decrease from the reported $-44.551M in 2025. Projections indicate $22.23M in 2027, and $45.79M in 2028.